Assignee
SHENZHEN RHEGEN BIOTECHNOLOGY CO LTD
CN·5 granted patents·4 pending applications·1 citations·filing 2020–2024
Top patents by PatentIndex Score
9 records- 0188US11707528B2Mannose-based mRNA targeted delivery system and use thereofSHENZHEN RHEGEN BIOTECHNOLOGY CO LTD·Filed 2021·Granted Jul 25, 2023·1 cites·10 claims
- 0270US2023355776A1Mannose-Based mRNA Targeted Delivery System and Use ThereofSHENZHEN RHEGEN BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 0368US11759532B2mRNA targeting molecule comprising N-acetylgalactosamine binding polypeptide and preparation method thereforSHENZHEN RHEGEN BIOTECHNOLOGY CO LTD·Filed 2022·Granted Sep 19, 2023·0 cites·23 claims
- 0467US11931410B1SARS-CoV-2 mRNA vaccine and preparation method and use thereofSHENZHEN RHEGEN BIOTECHNOLOGY CO LTD·Filed 2022·Granted Mar 19, 2024·0 cites·20 claims
- 0565US12325676B2Cationic lipid compound and composition for delivery of nucleic acids and use thereofSHENZHEN RHEGEN BIOTECHNOLOGY CO LTD·Filed 2024·Granted Jun 10, 2025·0 cites·13 claims
- 0662US12454712B2Method for large-scale synthesis of long-chain RNA and method for site-specific modification of long-chain RNASHENZHEN RHEGEN BIOTECHNOLOGY CO LTD·Filed 2022·Granted Oct 28, 2025·0 cites·20 claims
- 0762US2024180836A1Cationic Lipid Compound and Composition for Delivery of Nucleic Acids and Use ThereofSHENZHEN RHEGEN BIOTECHNOLOGY CO LTD·Filed 2024·Application pending·0 cites
- 0858US2023111107A1Method for preparing mrna-galnac targeting molecule, in vivo delivery system therefor, and use thereofSHENZHEN RHEGEN BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 0952US2023304058A1Novel 5'cap analog having cap2 structure and preparation method thereforSHENZHEN RHEGEN BIOTECHNOLOGY CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHENZHEN RHEGEN BIOTECHNOLOGY CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →